Analystreport

aTyr Pharma Inc (NASDAQ: LIFE) had its "buy" rating re-affirmed by analysts at Oppenheimer Holdings Inc..

aTyr Pharma, Inc.  (LIFE) 
Last atyr pharma, inc. earnings: 3/26 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: atyrpharma.com/investors-media